rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2002-4-4
|
pubmed:abstractText |
Intravenous cytostatic agents as second-line treatment of epithelial ovarian carcinoma have been withheld from many elderly patients because of fear of toxicity. The purpose of the study is to compare the toxicity and efficacy between elderly (older than 65 years of age) and younger (younger than 65 years of age) patients receiving intravenous second-line treatment of epithelial ovarian carcinoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1961-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11932898-Age Factors,
pubmed-meshheading:11932898-Aged,
pubmed-meshheading:11932898-Aging,
pubmed-meshheading:11932898-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11932898-Carboplatin,
pubmed-meshheading:11932898-Epithelial Cells,
pubmed-meshheading:11932898-Female,
pubmed-meshheading:11932898-Humans,
pubmed-meshheading:11932898-Middle Aged,
pubmed-meshheading:11932898-Neoplasm Recurrence, Local,
pubmed-meshheading:11932898-Ovarian Neoplasms,
pubmed-meshheading:11932898-Paclitaxel,
pubmed-meshheading:11932898-Retrospective Studies,
pubmed-meshheading:11932898-Survival Rate,
pubmed-meshheading:11932898-Topotecan
|
pubmed:year |
2002
|
pubmed:articleTitle |
Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma.
|
pubmed:affiliation |
Department of Oncology 5073, Finsen Center, Rigshospitalet, 9 Blegdamsvej, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark. bo.gronlund@dadlnet.dk
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|